The Pershing Square Sohn Cancer Research Alliance has announced the winners of the 2015 Pershing Square Sohn Prize for Young Investigators in Cancer Research.

Established in 2013 as part of a $25 million partnership between the Pershing Square and Sohn Conference foundations, the annual prize aims to catalyze collaboration among young investigators, academics, nonprofits, investors, and the biotech and pharmaceutical industries. This year's prize-winners will each receive $200,000 per year for up to three years to enable them to pursue cutting-edge research at a stage in their research when traditional funding is lacking.

The 2015 cohort Pershing Square Sohn Prize winners includes Timothy Chan, M.D., Ph.D. (Memorial Sloan Kettering Cancer Center); Arvin Dar, Ph.D.(Icahn School of Medicine at Mount Sinai); Evripidis Gavathiotis, Ph.D. (Albert Einstein College of Medicine at Yeshiva University); Moritz Kircher, M.D., Ph.D. (Sloan Kettering); Christine Mayr, M.D., Ph.D. (Sloan Kettering); and Sohail Tavazoie, M.D., Ph.D. (Rockefeller University).

In addition, in recognition of their excellent work, two finalists, Christopher Mason, Ph.D. (Weill Cornell Medical College) and Christopher Vakoc, M.D., Ph.D. (Cold Spring Harbor Laboratory), were awarded funding for a year and encouraged to reapply next year.

"We are pleased to announce this second cohort of outstanding Pershing Square Sohn Prize winners," said Bill Ackman, co-founder of the Pershing Square Foundation and CEO of Pershing Square Capital Management, L.P. "With this prize, we are creating a critical opportunity for young, innovative scientists to realize their dreams and forge a new path to discovery and cures during a time in their career when funding is typically difficult to obtain. Our goal is to accelerate the potential for cures by backing the best young researchers."